User: Guest  Login
Title:

Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients.

Document type:
Journal Article
Author(s):
Platzbecker, U; Al-Ali, H K; Gattermann, N; Haase, D; Janzen, V; Krauter, J; Götze, K; Schlenk, R; Nolte, F; Letsch, A; Ottmann, O G; Kündgen, A; Lübbert, M; Germing, U; Wermke, M; Reinhard, H; Weiss, C; Lieder, K; Ehninger, G; Leismann, O; Giagounidis, A
Journal title abbreviation:
Leukemia
Year:
2014
Journal volume:
28
Journal issue:
3
Pages contribution:
696-8
Language:
eng
Fulltext / DOI:
doi:10.1038/leu.2013.325
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/24186004
Print-ISSN:
0887-6924
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX